Evome Medical Technologies (LNDZF) Short Interest Ratio & Short Volume $0.0040 0.00 (0.00%) As of 05/21/2025 Add Compare Share Share Short Interest Stock AnalysisChartHeadlinesSEC FilingsShort InterestBuy This Stock Evome Medical Technologies Short Interest DataEvome Medical Technologies (LNDZF) has a short interest of 7,500 shares. This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 1.1, indicating that it would take 1.1 days of the average trading volume of 44,354 shares to cover all short positions.Current Short Interest7,500 sharesPrevious Short Interest7,500 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$30.00Short Interest Ratio1.1 Days to CoverLast Record DateApril 30, 2025Today's Trading Volume0 sharesAverage Trading Volume44,354 sharesToday's Volume Vs. Average0% Short Selling Evome Medical Technologies? Sign up to receive the latest short interest report for Evome Medical Technologies and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartLNDZF Short Interest Over TimeLNDZF Days to Cover Over TimeLNDZF Percentage of Float Shorted Over Time Evome Medical Technologies Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20257,500 shares $30.00 No ChangeN/A1.1 $0.00 4/15/20257,500 shares $30.75 No ChangeN/A2.6 $0.00 3/31/20257,500 shares $84.00 No ChangeN/A0.3 $0.01 2/15/202511,900 shares $833.00 -55.1%N/A0.5 $0.07 1/31/202526,500 shares $1,987.50 No ChangeN/A0.5 $0.08 3/15/2024200 shares $38.00 -97.6%N/A0 $0.19 2/29/20248,200 shares $1,107.82 No ChangeN/A16.4 $0.14 2/15/20248,200 shares $1,312.00 +4,000.0%N/A2.4 $0.16 1/15/20245,200 shares $832.00 No ChangeN/A0.5 $0.16 12/31/20235,200 shares $788.32 No ChangeN/A14.7 $0.15 Get the Latest News and Ratings for LNDZF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Evome Medical Technologies and its competitors with MarketBeat's FREE daily newsletter. 12/15/20235,200 shares $520.00 +2,500.0%N/A1.2 $0.10 11/30/2023200 shares $35.78 No ChangeN/A0.1 $0.18 11/15/2023200 shares $31.08 No ChangeN/A0 $0.16 10/31/2023200 shares $31.08 -90.9%N/A0.2 $0.16 10/15/20232,200 shares $352.00 +1,000.0%N/A0.2 $0.16 9/30/2023200 shares $40.00 No ChangeN/A0 $0.20 9/15/2023200 shares $32.20 No ChangeN/A0.3 $0.16 8/31/2023200 shares $32.20 No ChangeN/A0.1 $0.16 8/15/2023200 shares $41.18 No ChangeN/A0 $0.21 7/31/2023200 shares $60.00 -86.7%N/A0 $0.30 7/15/20231,500 shares $320.10 No ChangeN/A0.5 $0.21 6/30/20231,500 shares $282.90 -40.0%N/A0.1 $0.19 6/15/20232,500 shares $500.00 No ChangeN/A0.1 $0.20 3/31/20234,600 shares $1,242.00 No ChangeN/A1 $0.27 2/28/202314,600 shares $4,771.28 No ChangeN/A1.2 $0.33 12/15/20221,900 shares $703.00 No ChangeN/A0.2 $0.37 11/15/202294,200 shares $36,587.28 No ChangeN/A0 $0.39 10/31/202294,200 shares $36,587.28 +3.3%N/A17.8 $0.39 10/15/202291,200 shares $36,480.00 -1.1%N/A36.5 $0.40 9/30/202292,200 shares $42,015.54 +1.0%N/A8.6 $0.46 9/15/202291,300 shares $43,824.00 -18.0%N/A25.4 $0.48 8/31/2022111,300 shares $55,816.95 +62.7%N/A5.9 $0.50 8/15/202268,400 shares $41,710.32 +10.7%N/A1.3 $0.61 7/31/202261,800 shares $37,698.00 +6.2%N/A6.6 $0.61 7/15/202258,200 shares $34,774.50 +1.4%N/A52.9 $0.60 6/30/202257,400 shares $31,518.34 +0.2%N/A19.8 $0.55 6/15/202257,300 shares $33,884.36 -28.5%N/A13.6 $0.59 5/31/202280,100 shares $41,037.63 +220.4%N/A6.2 $0.51 5/15/202225,000 shares $13,750.00 No ChangeN/A2.3 $0.55 4/30/202225,000 shares $15,942.50 +6.4%N/A1.4 $0.64Buffett’s $325 Billion Cash Problem — Solved by Gold? (Ad)A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most investors are still asleep… but not for long. Garrett Goggin’s latest research reveals how you can “front-run” the greatest investor alive by positioning in four small miners sitting on up to 100X potential upside. When this hits the news — it’ll be too late. Discover how you could front-run Buffett’s gold move with Garrett’s Top Four picks. 4/15/202223,500 shares $14,864.22 +11.9%N/A5.5 $0.63 3/31/202221,000 shares $9,450.00 -6.7%N/A4.8 $0.45 3/15/202222,500 shares $9,389.25 -43.3%N/A11.3 $0.42 2/28/202239,700 shares $17,468.00 -5.9%N/A5 $0.44 2/15/202242,200 shares $16,036.00 -17.4%N/A2.6 $0.38 1/31/202251,100 shares $24,323.60 +12.1%N/A1.8 $0.48 LNDZF Short Interest - Frequently Asked Questions What is Evome Medical Technologies' current short interest? Short interest is the volume of Evome Medical Technologies shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 7,500 shares of LNDZF short. Learn More on Evome Medical Technologies' current short interest. What is a good short interest ratio for Evome Medical Technologies? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. LNDZF shares currently have a short interest ratio of 1.0. Learn More on Evome Medical Technologies's short interest ratio. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology S.A. ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit, Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks. What does it mean to sell short Evome Medical Technologies stock? Short selling LNDZF is an investing strategy that aims to generate trading profit from Evome Medical Technologies as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Evome Medical Technologies? A short squeeze for Evome Medical Technologies occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of LNDZF, which in turn drives the price of the stock up even further. How often is Evome Medical Technologies' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LNDZF, twice per month. The most recent reporting period available is April, 30 2025. More Short Interest Resources from MarketBeat Related Companies AKSY Short Interest Data ATAO Short Interest Data ADLI Short Interest Data LCDX Short Interest Data EMED Short Interest Data FSPKF Short Interest Data BEATW Short Interest Data LUCYW Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:LNDZF) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredSilver Is the New Oil—And the World’s Running DryElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evome Medical Technologies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Evome Medical Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.